hit counter

Lithium For Anxiety Disorders: An Unconventional, Underinvestigated Intervention

Elemental lithium was first discovered by Johann August Arfvedson in 1817 and was later isolated via electrolysis of lithium oxide (Li2O) through a joint effort of William Thomas Brande and Sir Humphrey Davy.  In the 19th century, scientists discovered that lithium was capable of dissolving uric acid crystals isolated from kidneys, and for this reason, …

Read more

Trichotillomania (Hair Pulling Disorder): Causes, Symptoms, Treatment

Trichotillomania is psychiatrically classified as subtype of obsessive compulsive disorder characterized chiefly by the urge to pull out one’s own hair.  The condition, also known as “hair pulling disorder,” affects upwards of 2.5 million individuals in the United States at some point during their lives.  Onset of trichotillomania occurs most frequently between 9 and 13 …

Read more

Intermittent Explosive Disorder (IED): Causes, Symptoms, Treatment

Intermittent explosive disorder (IED) is regarded as a subtype of impulse control disorder characterized by impulsive, uncontrollable explosive outbursts of anger, aggression, and/or rage – sometimes accompanied by violence.  To be considered intermittent explosive disorder, the explosive outbursts of anger must be triggered in situations and/or conditions in which such anger is unjustified.  In other …

Read more

Impulse Control Disorder (ICD): Causes, Symptoms, Treatment

Impulse control disorder (ICD) is an overarching classificatory label given to psychiatric disorders characterized by inability to resist impulses (or urges) that yield deleterious implications.  Examples of impulse control disorders include: compulsive gambling, incessant sexual encounters, and binge shopping.  If unrecognized and/or unaddressed for an extended duration, an impulse control disorder may ruin a person’s: …

Read more

20+ New Schizophrenia Medications In Development (2015)

It is estimated that over 2.5 million adults in the United States have been diagnosed with schizophrenia; this equates to approximately 1.1% of the population.  There are many different types of schizophrenia, in fact, genetic clusters suggest it is 8 distinct diseases.  Therefore not everyone diagnosed with schizophrenia has the same set of symptoms. Certain …

Read more

Nanotechnology For Depression: The Futuristic Potential of Nanopsychiatry

Most pharmacological-based treatments for depression aim to increase levels of various neurotransmitters, particularly serotonin (5-HT).  It is thought that approximately 2 out of 3 individuals that seek treatment with standard antidepressants such as SSRIs and SNRIs are able to attain therapeutic relief.  For a certain percentage of these individuals, the benefits of using pharmaceutical interventions …

Read more

Antidepressant Trials May Exclude Over 82% of People with Depression

A recent publication in the Journal of Psychiatric Practice documented that nearly 4/5 individuals diagnosed with major depression are considered ineligible to participate in clinical trials for new antidepressant drugs.  This means that for every 5 individuals with depression that attempt to join an antidepressant clinical trial, only one will meet inclusion criteria for registration.  …

Read more